curasan entered into an exclusive agreement whereby Implantcast will distribute CERASORB pure-phase beta-tricalcium phosphate bone regeneration products in Austria, Germany and Switzerland. Discussions are underway to extend the agreement to other countries in Implantcast’s network.
Implantcast’s products include primary, revision and tumor endoprostheses for hip, knee, extremities and thumb, as well as patient-specific implants.
curasan, based in Germany, has undertaken a variety of activities to grow its global reach. In 2016, the company announced its intent to target sales and marketing growth in the U.S. and China. The company entered the U.S. bone graft substitute market in 2Q17 with CERASORB Ortho Foam bone graft, and earlier this month, entered into a private label distribution agreement with Xtant Medical to distribute Matriform synthetic scaffolds in North America.
Sources: curasan AG; ORTHOWORLD Inc.
curasan entered into an exclusive agreement whereby Implantcast will distribute CERASORB pure-phase beta-tricalcium phosphate bone regeneration products in Austria, Germany and Switzerland. Discussions are underway to extend the agreement to other countries in Implantcast's network.
Implantcast's products include primary, revision and tumor...
curasan entered into an exclusive agreement whereby Implantcast will distribute CERASORB pure-phase beta-tricalcium phosphate bone regeneration products in Austria, Germany and Switzerland. Discussions are underway to extend the agreement to other countries in Implantcast’s network.
Implantcast’s products include primary, revision and tumor endoprostheses for hip, knee, extremities and thumb, as well as patient-specific implants.
curasan, based in Germany, has undertaken a variety of activities to grow its global reach. In 2016, the company announced its intent to target sales and marketing growth in the U.S. and China. The company entered the U.S. bone graft substitute market in 2Q17 with CERASORB Ortho Foam bone graft, and earlier this month, entered into a private label distribution agreement with Xtant Medical to distribute Matriform synthetic scaffolds in North America.
Sources: curasan AG; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
